Home › Companies › Tango Therapeutics, Inc. › 2024-2025

Tango Therapeutics, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated October 14, 2026.

  • 7Reported items
  • 127Asset managers
  • 857Fund votes
  • June 5, 2025Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Tango Therapeutics, Inc. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Tango Therapeutics, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Tango Therapeutics, Inc. 2024-2025 meeting

Each item below shows how the 127 asset managers that disclosed a Tango Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Tango Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. ELECTION OF CLASS I DIRECTOR: LESLEY ANN CALHOUN

No official resultsDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

90% of fund votes cast · no official result

FOR
Details: votes by 42 asset managers

The 42 asset managers below reported 9,821,019 for, 1,052,864 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,821,019WITHHOLD: 1,052,864
Largest asset managers voting on “ELECTION OF CLASS I DIRECTOR: LESLEY ANN CALHOUN” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional00 0290,942Withhold
Jackson National173,3200 013,229Mixed
Equitable88,7650 064,940Mixed
TIAA141,5970 00For
SEI00 0131,130Withhold
BRIDGEWAY FUNDS INC00 0125,000Withhold
ETF Series Solutions00 065,327Withhold
American Century00 065,152Withhold
Putnam62,5750 00For
Invesco00 044,598Withhold
Lincoln Financial00 038,000Withhold
ETFis Series Trust I00 035,826Withhold
Global X00 028,323Withhold
Northern Trust00 027,621Withhold
AIG/SunAmerica00 023,373Withhold
John Hancock00 019,340Withhold
Pacific Life15,8910 00For
ProShares00 014,722Withhold
Voya00 014,398Withhold
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

2. TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF…

No official resultsCAPITAL STRUCTURE

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 42 asset managers

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 200,000,000 TO 400,000,000.

The 42 asset managers below reported 10,873,583 for, 300 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,873,583AGAINST: 300
Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional290,9420 00For
Jackson National186,5490 00For
Equitable153,7050 00For
TIAA141,5970 00For
SEI131,1300 00For
BRIDGEWAY FUNDS INC125,0000 00For
ETF Series Solutions65,3270 00For
American Century65,1520 00For
Putnam62,5750 00For
Invesco44,5980 00For
Lincoln Financial38,0000 00For
ETFis Series Trust I35,8260 00For
Global X28,3230 00For
Northern Trust27,6210 00For
AIG/SunAmerica23,3730 00For
John Hancock19,3400 00For
Pacific Life15,8910 00For
ProShares14,7220 00For
Voya14,3980 00For
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

3. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

87% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 123 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 42 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab0548,652 00Against
Dimensional0290,942 00Against
Jackson National173,32013,229 00Mixed
Equitable153,7050 00For
TIAA141,5970 00For
SEI0131,130 00Against
BRIDGEWAY FUNDS INC125,0000 00For
ETF Series Solutions65,3270 00For
American Century065,152 00Against
Putnam62,5750 00For
Invesco044,598 00Against
Lincoln Financial38,0000 00For
ETFis Series Trust I35,8260 00For
Global X028,323 00Against
Northern Trust27,6210 00For
AIG/SunAmerica23,3730 00For
John Hancock19,3400 00For
Pacific Life15,8910 00For
ProShares14,7220 00For
Voya14,3980 00For
Nationwide12,2610 00For

Fund voting reports, all 42 managers: 9,751,557 for, 1,122,326 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 97 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
TRV GP IV, LLC16,859,0750 00For
TCG Crossover Management, LLC10,736,0000 00For
GILEAD SCIENCES, INC.4,854,4430 00For
FARALLON CAPITAL MANAGEMENT LLC03,812,392 00Against
T. Rowe Price3,264,9860 00For
Nantahala Capital Management, LLC2,747,0970 00For
Siren, L.L.C.2,245,7610 00For
BlackRock1,719,532349 00For
MARSHALL WACE, LLP01,496,029 00Against
BESSEMER TRUST Co NATIONAL ASSOCIATION1,416,7680 00For
GEODE CAPITAL MANAGEMENT, LLC1,370,7110 00For
State Street989,9840 00For
BALYASNY ASSET MANAGEMENT L.P.0879,088 00Against
ArrowMark Colorado Holdings LLC0708,385 00Against
BESSEMER TRUST CO708,3840 00For
BESSEMER TRUST Co OF FLORIDA708,3840 00For
Bessemer Trust CO of Delaware, N.A.708,3840 00For
Bessemer Trust Co of Nevada, National Association708,3840 00For
Samsara BioCapital, LLC630,0000 00For
ORBIMED ADVISORS LLC0550,000 00Against
Charles Schwab0548,652 00Against
Woodline Partners LP441,9040 00For
JACOBS LEVY EQUITY MANAGEMENT, INC387,1350 00For
Northern Trust320,7580 00For
Asset Management One Co., Ltd.224,0770 00For

Institutional-manager reports, all 97 managers: 52,633,399 for, 8,535,802 against, 18,034 1 year. Showing the 25 largest; see all in the interactive database.

4. NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED…

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 121 asset managers

Description as filed by funds: NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 42 asset managers voting on “NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR N” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
T. Rowe Price00 00--
Fidelity00 00--
Charles Schwab00 00--
Dimensional00 00--
Jackson National00 00--
Equitable00 00--
TIAA00 00--
SEI00 00--
BRIDGEWAY FUNDS INC00 00--
ETF Series Solutions00 00--
American Century00 00--
Putnam00 00--
Invesco00 00--
Lincoln Financial00 00--
ETFis Series Trust I00 00--
Global X00 00--
Northern Trust00 00--
AIG/SunAmerica00 00--
John Hancock00 00--
Pacific Life00 00--
ProShares00 00--
Voya00 00--
Nationwide00 00--

Fund voting reports, all 42 managers: 10,569,712 1 year, 304,171 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 95 asset managers voting on “NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR N” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
EcoR1 Capital, LLC00 00--
GILEAD SCIENCES, INC.00 00--
FARALLON CAPITAL MANAGEMENT LLC3,812,3920 00For
T. Rowe Price00 00--
Siren, L.L.C.00 00--
Blue Owl Capital Holdings LP2,146,6520 00For
BlackRock00 00--
MARSHALL WACE, LLP00 00--
BESSEMER TRUST Co NATIONAL ASSOCIATION00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
State Street00 00--
BALYASNY ASSET MANAGEMENT L.P.00 00--
ArrowMark Colorado Holdings LLC00 00--
BESSEMER TRUST CO00 00--
BESSEMER TRUST Co OF FLORIDA00 00--
Bessemer Trust CO of Delaware, N.A.00 00--
Bessemer Trust Co of Nevada, National Association00 00--
Samsara BioCapital, LLC00 00--
ORBIMED ADVISORS LLC00 00--
Charles Schwab00 00--
Woodline Partners LP00 00--
JACOBS LEVY EQUITY MANAGEMENT, INC00 00--
Northern Trust00 00--
Asset Management One Co., Ltd.00 00--
CONGRESS ASSET MANAGEMENT CO00 00--

Institutional-manager reports, all 95 managers: 5,979,665 for, 284 against, 37,357,840 1 year, 90,488 3 year. Showing the 25 largest; see all in the interactive database.

5. To vote on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on executive…

No official resultsSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 3 asset managers

Description as filed by funds: To vote on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on executive compensation

The 3 asset managers below reported 27,789,249 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 27,789,249
Largest asset managers voting on “To vote on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on executive ” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
TRV GP IV, LLC16,859,0750 00For
TCG Crossover Management, LLC10,736,0000 00For
TRV GP VI, LLC194,1740 00For

6. Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsSECTION 14A SAY-ON-PAY VOTES

0% of fund votes cast · no official result

AGAINST
Details: votes by 2 asset managers

The 2 asset managers below reported 67,742 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

AGAINST: 67,742
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ALGERT GLOBAL LLC045,180 00Against
JPMorgan022,562 00Against

7. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the…

No official resultsAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 42 asset managers

Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

The 42 asset managers below reported 10,873,583 for, 300 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,873,583AGAINST: 300
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at Tango Therapeutics, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,810,5900 00For
BlackRock2,103,4720 00For
T. Rowe Price1,631,1130 00For
Fidelity1,210,3940 00For
Charles Schwab548,6520 00For
Dimensional290,9420 00For
Jackson National186,5490 00For
Equitable153,7050 00For
TIAA141,5970 00For
SEI131,1300 00For
BRIDGEWAY FUNDS INC125,0000 00For
ETF Series Solutions65,3270 00For
American Century65,1520 00For
Putnam62,5750 00For
Invesco44,5980 00For
Lincoln Financial38,0000 00For
ETFis Series Trust I35,8260 00For
Global X28,3230 00For
Northern Trust27,6210 00For
AIG/SunAmerica23,3730 00For
John Hancock19,3400 00For
Pacific Life15,8910 00For
ProShares14,7220 00For
Voya14,3980 00For
Nationwide12,2610 00For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

Largest Tango Therapeutics, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 108,107,890 shares outstanding at the time of that meeting.

Fund voting reports: top Tango Therapeutics, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 3.52%
2BlackRock 1.95%
3T. Rowe Price 1.51%
4Fidelity 1.12%
5Charles Schwab 0.51%
6Dimensional 0.27%
7Jackson National 0.17%
8Equitable 0.14%
9TIAA 0.13%
10SEI 0.12%
Institutional-manager reports: top Tango Therapeutics, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.”, 2024-2025
#Asset manager % of shares outstanding
1TRV GP IV, LLC 15.59%
2TCG Crossover Management, LLC 9.93%
3GILEAD SCIENCES, INC. 4.49%
4FARALLON CAPITAL MANAGEMENT LLC 3.53%
5T. Rowe Price 3.02%
6Nantahala Capital Management, LLC 2.54%
7Siren, L.L.C. 2.08%
8BlackRock 1.59%
9MARSHALL WACE, LLP 1.38%
10BESSEMER TRUST Co NATIONAL ASSOCIATION 1.31%

Reported Tango Therapeutics, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Tango Therapeutics, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
RTW Investments, LP 12.30% 13G
Adage Capital Management, L.P. 11.85% 13G
TCG Crossover GP II, LLC 10.73% 13G
Farallon Partners, L.L.C. 10.14% 13G
Entities affiliated with Boxer Capital, LLC 9.90% DEF14A
EcoR1 Capital, LLC 9.82% DEF14A
TCG Crossover II 9.71% DEF14A
FMR LLC 9.16% 13G
Woodline Partners LP 7.40% 13G
Nextech Crossover I GP S.a. r.l. 6.72% 13G

Percentages above are of 108,107,890 shares outstanding, as reported by Tango Therapeutics, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Tango Therapeutics, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Tango Therapeutics, Inc.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 127 asset managers reported how they voted in their SEC Form N-PX filings, covering 857 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — the reporting funds and managers cast 87% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Tango Therapeutics, Inc. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.